Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1071 of 6351
-
New drug combo shows promise for tough liver cancer
Disease control CompletedThe purpose of this study is to observe and preliminary explore the efficacy and safety of combination of Apatinib and SHR-1210 regimen in treating advanced hepatocellular carcinoma.
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for aggressive breast cancer: drug cocktails show promise in trial
Disease control OngoingThis study is to assess the efficacy and safety of olaparib monotherapy versus olaparib in combination with an inhibitor of ATR (Ataxia-Telangiectasia Mutated (ATM) and Rad3-related protein kinase (Ceralasertib \[AZD6738\]) and olaparib monotherapy versus olaparib in combination …
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Rituximab vs. azathioprine: which drug better prevents EGPA flares?
Disease control CompletedThe purpose of this study is to investigate, after achievement of remission, the efficacy of rituximab compared with azathioprine maintenance therapy on duration of remission, in patients with relapsing or newly-diagnosed Eosinophilic granulomatosis with polyangiitis EPGA receivi…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New cocktail of drugs shows promise for Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to: a) establish the recommended phase 2 dose (RP2D) and to evaluate the antitumor activity and safety of niraparib combination therapies (Combinations 1 and 2) and b) to determine the relative bioavailability of niraparib and abiraterone acetate (AA)…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New clip device could spare High-Risk heart patients from open surgery
Disease control OngoingThe objective of the study is to demonstrate the non-inferiority for clinical efficacy of an endovascular treatment strategy with the MitraClip® in comparison with a surgical treatment strategy in patients with severe primary mitral regurgitation judged eligible for anatomical re…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Parent stem cells offer new hope for kids with blood cancer
Disease control OngoingThis is a Phase I/II study designed to evaluate the kinetics of hematopoietic reconstitution and the incidence of acute chronic GVHD after partially matched related donor hematopoietic cell transplantation using an αβTCR/CD19+ cell depleted graft.
Phase 1/2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Friendly bacteria in a nasal spray might tame Kids' allergies
Disease control CompletedAllergic rhinoconjunctivitis is a pathology of the nasal and conjunctival mucosa induced by Immunoglobulin E (IgE) mediated inflammation following allergic exposure. This condition represents a global health problem that affects 5 to 20% of the population. As with all allergic di…
Phase 3 • Sponsor: Federico II University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo treatment matches standard for esophageal cancer
Disease control CompletedThis retrospective real-world study aimed to compare neoadjuvant immunochemotherapy (NICT) and neoadjuvant chemoradiotherapy (NCRT) followed by esophagectomy in patients with locally advanced esophageal squamous cell carcinoma (ESCC). A total of 203 consecutive patients treated a…
Sponsor: Yongtao Han • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Heart pouch procedure may beat blood thinners for stroke prevention
Disease control CompletedThe study goal is to determine the clinical benefit of percutaneous catheter-based left atrial appendage (LAA) closure in patients with non-valvular atrial fibrillation (NVAF) at high risk of stroke (CHA2DS2-VASc Score ≥2) as well as high risk of bleeding as compared to best medi…
Phase 4 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can primary care clinics help curb the opioid crisis? a major trial tests a Team-Based model
Disease control CompletedEffective treatment for opioid use disorders (OUDs) requires medications. Two medications for treating OUDs-buprenorphine and injectable naltrexone-can be prescribed in primary care (PC). However, despite the current opioid epidemic and expert recommendations that OUDs should be …
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo shows promise for tough breast cancer
Disease control CompletedThis trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. It will find out what side effects happen when participants get these two drugs. A side effect is anything the drugs do besides treating cancer. Pembrolizumab is a dru…
Phase 1/2 • Sponsor: Seagen Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Magic mushroom compound shows promise for tough depression
Symptom relief OngoingThe primary goal of this pilot study is to investigate whether psilocybin alters neuroplasticity in people with major depressive disorder. The primary hypothesis is that psilocybin will result in neuroplastic changes that parallel improvement in symptoms of depression.
Phase 1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Sound waves vs. Parkinson's: new ultrasound treatment shows promise
Disease control CompletedThe objective of this study is to test the efficacy and safety of unilateral subthalamotomy performed using the ExAblate System for the treatment of Parkinson's disease (PD) motor features.
Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immunotherapy combo shows promise for Hard-to-Treat ovarian cancer
Disease control CompletedThere are several data suggesting that pembrolizumab and bevacizumab may be synergistic. Enhanced tumor angiogenesis is commonly associated with absence of tumor-infiltrating T cells in patients. There is evidence in OC that tumor expression of VEGF is negatively correlated to th…
Phase 2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 26, 2026 15:25 UTC
-
Pinpoint radiation may spare the brain in lung cancer that spreads
Disease control OngoingThis research study is studying stereotactic radiation (focused/pinpoint radiation that targets each individual tumor but not the surrounding brain) instead of whole-brain radiation (radiation targeting the entire brain) as a possible treatment for patients with small cell lung c…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New combo therapy aims to tame tough Crohn's cases
Disease control Recruiting nowCrohn's Disease (CD) is an inflammatory bowel disease. It can lead to significant complications and discomfort in the stomach and intestines. Crohn's disease is a debilitating, incurable disease of immune cells; it affects almost 1 million people in the United States. CD is chara…
Phase 2 • Sponsor: Aaron Etra • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug duo aims to control lymphoma without chemo
Disease control OngoingThis phase II trial studies how well obinutuzumab and ibrutinib work as front line therapy in treating patients with indolent non-Hodgkin's lymphoma. Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. Ibrutinib may stop…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can vaccines keep breast cancer away? new study tests two options
Prevention OngoingThe main purpose of this study is to evaluate the safety of each study vaccine and to evaluate the effect on the time to disease recurrence (assessed by disease free survival). Participants will be assigned to receive one of two study vaccines (DC1 study vaccine vs. WOKVAC). The…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New hope for advanced cancer: adding local treatment may extend life
Disease control Recruiting nowThis phase II trial studies how well chemotherapy with or without radiation or surgery works in treating participants with esophageal or gastric cancer that has spread to less than 3 places in the body (oligometastatic). Drugs used in chemotherapy, such as fluorouracil and capeci…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Diabetes kidney drug shows promise in slowing damage
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC